Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Ethambutol and Acute Kidney Injury

Risk Factors and Prevention

  • Pre-existing renal insufficiency significantly increases the risk of ethambutol nephrotoxicity 1
  • Higher doses (>30 mg/kg/day) of ethambutol increase the risk of all toxicities, including renal effects 1
  • Renal function should be monitored regularly during ethambutol therapy, especially in patients with pre-existing renal impairment 1
  • Ethambutol dosage must be adjusted in patients with renal insufficiency to prevent accumulation and toxicity 1
  • For patients with end-stage renal disease, ethambutol should be administered at a dose of 15-20 mg/kg three times a week after dialysis 1

Clinical Presentation and Diagnosis

  • AKI is diagnosed by a 50% or greater sustained increase in serum creatinine over a short period of time, reflected as a rapid decrease in eGFR 2
  • People with diabetes are at higher risk of AKI than those without diabetes 2

REFERENCES

1

Ethambutol-Induced Renal Injury Mechanism [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025